
Actinium Pharmaceuticals to Present at the 23rd Annual BioCentury Future Leaders in the Biotech Industry Conference
NEW YORK, NY--(Marketwired - March 11, 2016) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers announced …